Drug Therapy Problem Identification and Resolution by Clinical Pharmacists in a Family Medicine Residency Clinic

Abstract


 Purpose: There are limited data to evaluate the impact of ambulatory clinical pharmacist recommendations on family medicine resident prescribing and monitoring of medications. The purpose of this study is to begin to gain insight in this area by answering the research question, “How many ambulatory clinical pharmacist recommendations for drug therapy problem (DTP) resolution are implemented on the day of a medication therapy management (MTM) visit in an outpatient family medicine residency clinic?”
 Methods: This is a retrospective chart review of face-to-face MTM encounters conducted by ambulatory clinical pharmacists (including pharmacist residents) from August 1, 2012 to June 30, 2015 at a family medicine residency clinic. Descriptive statistics were conducted to both quantify the number of DTPs identified and resolved on the day of the MTM visit as well as categorize the DTPs.
 Results: Based on the 728 MTM encounters analyzed, patients were an average of 53.6 years old and took 11.9 medications to treat 5.7 medical conditions. A total of 3057 DTPs were identified in the 728 encounters, of which 1303 were resolved the same day as the MTM visit. This resulted in an average of 4.2 DTPs identified and 2.0 resolved per visit per patient. The most common DTP category identified in this study was the need for additional drug therapy (41.6%).
 Conclusions: Approximately half of the ambulatory clinical pharmacist’s DTP resolution recommendations were implemented the same day they were identified, which highlights the strength of team-based patient care and interprofessional collaboration in a residency teaching clinic.
 
 Conflict of Interest We declare no conflicts of interest or financial interests that the authors or members of their immediate families have in any product or service discussed in the manuscript, including grants (pending or received), employment, gifts, stock holdings or options, honoraria, consultancies, expert testimony, patents and royalties.
 Treatment of Human Subjects: IRB determined project was non-HSR
 
 Type: Original Research

Drug-related problems in Ethiopian public healthcare settings: Systematic review and meta-analysis

“… 14 , 17 , 18 Hence, identifying risk factors, timely medication therapy review and taking correction measures for identified DRPs are important to reduce the harmful outcomes of DRPs. 19 – 22 Data about the prevalence of DRPs in a healthcare system would be useful to plan and implement strategies to reduce the incidence and resolve a DRP before it harms the patient. Hence, this systematic review and meta-analysis was undertaken with the aim of quantifying the prevalence of DRPs and identifying commonly encountered types of DRPs in Ethiopian healthcare settings.…”

Comprehensive Medication Management Services with a Holistic Point of View, a Scoping Review

“…In 32 of the quantitative studies, PI actions were not detailed. PIs were not described in the descriptive and retrospective studies [ 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 ]. Other sources only focused on the impacts or level of acceptance of PIs or just show general results of the service [ 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 ].…”

Drug therapy problems and health related quality of life among patients with colorectal cancer in a Kenyan tertiary health facility

“…This observation contradicts other findings that show poor outcomes when multiple drugs are used. 23 Refractoriness to the medication negatively affected social relations domains while drug interaction reduced psychological and overall HRQoL scores. This portrayed that the personal relationships deteriorated due to the stress of treatment not attaining the desired result.…”